Xianghui Xu

Dr. Xianghui Xu

Department of Pharmacy, College of Biology, Hunan University, Changsha 410082, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2016 in ACS Nano
Verified
Journal Article
Closed access
YLYachao Li
Yachao Li
XXXianghui Xu
Xianghui Xu
XZXiao Zhang
Xiao Zhang
YLYunkun Li
Yunkun Li
ZZZhijun Zhang
Zhijun Zhang
ZGZhongwei Gu
Zhongwei Gu

17 May 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
XZXiao Zhang
Xiao Zhang
XXXianghui Xu
Xianghui Xu
YLYachao Li
Yachao Li
Cheng HuCheng Hu
Cheng Hu
ZZZhijun Zhang
Zhijun Zhang
ZGZhongwei Gu
Zhongwei Gu

29 January 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SMShengnan Ma
Shengnan Ma
JZJie Zhou
Jie Zhou
YZYuxin Zhang
Yuxin Zhang
BYBo Yang
Bo Yang
He YiyanHe Yiyan
He Yiyan
ZGZhongwei Gu
Zhongwei Gu

26 February 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
XZXiao Zhang
Xiao Zhang
ZZZhijun Zhang
Zhijun Zhang
XXXianghui Xu
Xianghui Xu
YLYunkun Li
Yunkun Li
YLYachao Li
Yachao Li
ZGZhongwei Gu
Zhongwei Gu

16 July 2015 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
ZZZhijun Zhang
Zhijun Zhang
XZXiao Zhang
Xiao Zhang
XXXianghui Xu
Xianghui Xu
YLYunkun Li
Yunkun Li
YLYachao Li
Yachao Li
ZGZhongwei Gu
Zhongwei Gu

1 January 2016 in Theranostics
Verified
Journal Article
Open access
YLYunkun Li
Yunkun Li
YLYachao Li
Yachao Li
XZXiao Zhang
Xiao Zhang
XXXianghui Xu
Xianghui Xu
ZZZhijun Zhang
Zhijun Zhang
ZGZhongwei Gu
Zhongwei Gu
Recently, self-assembling small dendrimers into supramolecular dendritic systems offers an alternative strategy to develop multifunctional nanoplatforms for biomedical applications. We herein report a dual-responsive supramolecular PEGylated dendritic system for efficient platinum-based drug delivery and near-infrared (NIR) tracking. With a refined molecular/supramolecular engineering, supramolecular dendritic systems were stabilized by bioreducible disulfide bonds and endowed with NIR fluorescence probes, and PEGylated platinum derivatives coordinated onto the abundant peripheral groups of supramolecular dendritic templates to generate pH/redox dual-responsive theranostic supramolecular PEGylated dendritic systems (TSPDSs). TSPDSs markedly improved the pharmacokinetics and biodistribution of platinum-based drugs, owing to their stable nanostructures and PEGylated shells during the blood circulation. Tumor intracellular environment (low pH value and high glutathione concentration) could trigger the rapid disintegration of TSPDSs due to acid-labile coordination bonds and redox-cleavable disulfide linkages, and then platinum-based drugs were delivered into the nuclei to exert antitumor activity. In vivo antitumor treatments indicated TSPDSs not only provided high antitumor efficiency which was comparable to clinical cisplatin, but also reduced renal toxicity of platinum-based drugs. Moreover, NIR fluorescence of TSPDSs successfully visualized in vitro and in vivo fate of nanoplatforms and disclosed the intracellular platinum delivery and pharmacokinetics. These results confirm tailor-made supramolecular dendritic system with sophisticated nanostructure and excellent performance is a promising candidate as smart theranostic nanoplatforms.